Bioequivalence of Ulipristal 30 mg Tablets in Healthy Subjects Under Fasting Conditions
Phase 1
- Conditions
- o medical conditionTherapeutic area: Not possible to specify
- Registration Number
- CTIS2023-504258-36-00
- Lead Sponsor
- aboratorios Leon Farma S.A.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method